RE:RE:RE:RE:RE:RE:RE:RE:RE:Numbers out same old same old Both stocks are in the tank and were supposed to be IP gems. Neither have lived to potential. On one hand you have NextLeaf pumping itself with constant outreach and gettng no traction, on the other hand you have Sproutly sitting silent and getting no traction. Essentially they are one and the same with different ways of management handling their business.
The hype Paul has built gotten stale with over promise and under deliver, he has been that way from the start. Sproutly wasnt delivering so they stopped promising, not sure thats better but you wanted to compare so neither win!
Either way both stocks are a gong show right now. Becomes a choice to bet on the IP of one or the other. Do you pick the isolated molecules that can be replicated by anyone in a lab or do you go with the whole plant water soluble molecules that have never been replicated outside of a Sproutly/Infusion Biosciences lab. Choices, choices